Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Cash & Equivalents (2022 - 2023)

Historic Cash & Equivalents for Bluejay Diagnostics (BJDX) over the last 2 years, with Q3 2023 value amounting to $5.1 million.

  • Bluejay Diagnostics' Cash & Equivalents fell 6179.7% to $5.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $5.1 million, marking a year-over-year decrease of 6179.7%. This contributed to the annual value of $10.1 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, Bluejay Diagnostics' Cash & Equivalents is $5.1 million, which was down 6179.7% from $5.1 million recorded in Q2 2023.
  • Bluejay Diagnostics' Cash & Equivalents' 5-year high stood at $17.1 million during Q1 2022, with a 5-year trough of $5.1 million in Q3 2023.